
About Naman Global Impex
Naman Global Impex is a Healthcare company based in Mumbai (India). It supplies and exports generic, branded, and specialty medicines globally. It operates on a B2B and D2C model. Its Indian entity Naman Global Impex Private Limited reported revenue of βΉ10.14 Cr. Naman Global Impex offers products and services including Generic Medicines, Branded Medicines, Specialty Medicines, Syrups, and Tablets. Its focus areas include Pharmaceuticals, Generic Drugs, Anti-Biotics and Specialty Medicines. Similar companies include Entero Healthcare, Keimed and Sandor Medicaids; 3 of its 3 listed similar companies have raised funding.
Company details
Naman Global Impex Is A Supplier And Exporter Of Generic, Branded, And Specialty Medicines, Sourcing From Manufacturers Like Cipla And Sun Pharma. Based In Mumbai, India, They Focus On Categories Such As Anti-biotics, Oncology, And Nephrology. Their Activities Include Domestic Sales And Global Exports, Aiming To Provide Affordable Options To Underserved Populations Through Partnerships With Charitable Trusts.
- Headquarters Mumbai, India
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Website namanglobalimpex.com
- Legal Name Naman Global Impex Private Limited
- Date of Incorporation 25 Mar, 2014
- Jurisdiction Mumbai, Maharashtra, India
- Annual Revenue₹10.14 Cr
FY 2024 · -49% YoY
- Net Profit₹34.3 Lakh
FY 2024 · 3% margin
- EBITDA₹1.69 Cr
FY 2024 · 17% margin
Associated legal entities of Naman Global Impex
Naman Global Impex operates through Naman Global Impex Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Naman Global Impex Private Limited CIN U24110MH2014PTC254968 | Active | 25 Mar 2014 | Mumbai, Maharashtra | ₹10.1 Cr | 2 | View details |
Products & Services of Naman Global Impex
Naman Global Impex offers a comprehensive portfolio of products and services, including Generic Medicines, Branded Medicines, Specialty Medicines, Syrups, and Tablets.
Range of generic drugs for allergy and pain relief
Indian branded drugs from Cipla and Sun Pharma
Medicines for oncology and nephrology treatments
Liquid formulations for various health conditions
Solid dosage forms for daily medications
Board of directors of Naman Global Impex Private Limited (Naman Global Impex)
Naman Global Impex Private Limited is the primary company behind Naman Global Impex. The board of Naman Global Impex Private Limited currently have 2 directors; the longest-serving is Nirmal Mohanlal Sakaria, appointed in 2014. 3 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Nirmal Mohanlal Sakaria DIN 02574700 | Director | 25 Mar 2014 | 12 yrs 7 mo | Naman Global Impex Private Limited |
| Girish Mohanlal Sakaria DIN 02574694 | Director | 12 Mar 2024 | 2 yrs 7 mo | Naman Global Impex Private Limited |
Financials of Naman Global Impex
Figures of Naman Global Impex Private Limited, the primary company behind Naman Global Impex, for FY 2024. Revenue was ₹10.14 Cr (-49% year on year). Net profit was ₹34.3 Lakh (3% margin). EBITDA was ₹1.69 Cr (17% margin). Revenue has grown at a compounded annual rate of -21% over three years and -11% over five years.
- ₹10.14 CrRevenue · FY 2024 · -49% YoY
- ₹34.3 LakhNet profit · 3% margin
- ₹1.69 CrEBITDA · 17% margin
- ₹1 LakhPaid-up capital
- -21%Revenue CAGR, 3 years
- -11%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Naman Global Impex Private Limited are on its company page.
Detailed financial statements for Naman Global Impex
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Naman Global Impex
Naman Global Impex has 3 listed similar companies in our database, 3 of them funded. They include Entero Healthcare, Keimed and Sandor Medicaids.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| enterohealthcare.com | 2018 | Mumbai, India | $59.67M | 817 | India's leading healthcare products distribution platform | |
| keimed.com | 2000 | Hyderabad, India | $16.62M | 588 | Temperature-sensitive medicines are distributed via cold chain logistics by Keimed. | |
| sandor.co.in | 1995 | Hyderabad, India | $8.98M | 161 | Provider of medical equipment, devices, and drugs distribution services |
Detailed similar companies of Naman Global Impex
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Naman Global Impex
Naman Global Impex is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
The primary company behind Naman Global Impex, Naman Global Impex Private Limited, reported revenue of βΉ10.14 Cr for FY 2024, down 49% year on year.
Naman Global Impex Is A Supplier And Exporter Of Generic, Branded, And Specialty Medicines, Sourcing From Manufacturers Like Cipla And Sun Pharma. Based In Mumbai, India, They Focus On Categories Such As Anti-biotics, Oncology, And Nephrology. Their Activities Include Domestic Sales And Global Exports, Aiming To Provide Affordable Options To Underserved Populations Through Partnerships With Charitable Trusts.
Naman Global Impex's top competitors include Entero Healthcare, Keimed and Sandor Medicaids.
Naman Global Impex offers Generic Medicines, Branded Medicines, Specialty Medicines, Syrups, and Tablets.
Naman Global Impex operates through Naman Global Impex Private Limited.
The legal entities of Naman Global Impex currently have 2 directors, including Nirmal Mohanlal Sakaria, Girish Mohanlal Sakaria.